Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Decibel Cannabis Company Inc. is a leading Canadian consumer packaged goods company focused on the premium cannabis market. Formed through the merger of Westleaf Inc. and WeGrow BC, the company operates a vertically integrated business model encompassing cultivation, extraction, and brand management. Its diverse portfolio includes prominent brands such as General Admission, Qwest, and Vox, which lead in categories like craft flower and infused pre-rolls. The company operates high-capacity facilities, including 'The Plant' in Calgary for extraction and the Qwest Estate for ultra-premium cultivation. While primarily a commercial-stage retail and wholesale entity, its products utilize cannabinoid-based modalities to target therapeutic areas such as pain management and sleep support. Decibel is a major player in the Canadian recreational and medical cannabis landscapes, emphasizing quality and innovation in its delivery formats.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Decibel Cannabis Company.